BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17908803)

  • 1. E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus.
    Evangelou K; Kotsinas A; Mariolis-Sapsakos T; Giannopoulos A; Tsantoulis PK; Constantinides C; Troupis TG; Salmas M; Kyroudis A; Kittas C; Gorgoulis VG
    J Clin Pathol; 2008 May; 61(5):601-5. PubMed ID: 17908803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus.
    Yamazaki K; Hasegawa M; Ohoka I; Hanami K; Asoh A; Nagao T; Sugano I; Ishida Y
    J Clin Pathol; 2005 Sep; 58(9):904-10. PubMed ID: 16126868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas.
    Zacharatos P; Kotsinas A; Evangelou K; Karakaidos P; Vassiliou LV; Rezaei N; Kyroudi A; Kittas C; Patsouris E; Papavassiliou AG; Gorgoulis VG
    J Pathol; 2004 Jul; 203(3):744-53. PubMed ID: 15221933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of MUC1 and MUC4 expression in Barrett-associated oesophageal adenocarcinoma.
    Piessen G; Wacrenier A; Briez N; Triboulet JP; Van Seuningen I; Mariette C
    J Clin Pathol; 2009 Dec; 62(12):1144-6. PubMed ID: 19946103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis in the neoplastic sequence of Barrett's oesophagus. Correlation with VEGF expression.
    Couvelard A; Paraf F; Gratio V; Scoazec JY; Hénin D; Degott C; Fléjou JF
    J Pathol; 2000 Sep; 192(1):14-8. PubMed ID: 10951394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of survivin, p53, and caspase 3 in Barrett's esophagus carcinogenesis.
    Parenti A; Leo G; Porzionato A; Zaninotto G; Rosato A; Ninfo V
    Hum Pathol; 2006 Jan; 37(1):16-22. PubMed ID: 16360411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy?
    Boone J; Ten Kate FJ; Offerhaus GJ; van Diest PJ; Rinkes IH; van Hillegersberg R
    J Clin Pathol; 2008 Aug; 61(8):909-13. PubMed ID: 18474542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F-1 transcription factor immunoexpression is inversely associated with tumor growth in colon adenocarcinomas.
    Bramis J; Zacharatos P; Papaconstantinou I; Kotsinas A; Sigala F; Korkolis DP; Nikiteas N; Pazaiti A; Kittas C; Bastounis E; Gorgoulis VG
    Anticancer Res; 2004; 24(5A):3041-7. PubMed ID: 15517914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
    Abraham SC; Wang H; Wang KK; Wu TT
    Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase IX overexpression is associated with diminished prognosis in esophageal cancer and correlates with Her-2 expression.
    Birner P; Jesch B; Friedrich J; Riegler M; Zacherl J; Hejna M; Wrba F; Schultheis A; Schoppmann SF
    Ann Surg Oncol; 2011 Nov; 18(12):3330-7. PubMed ID: 21519917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.
    Glickman JN; Blount PL; Sanchez CA; Cowan DS; Wongsurawat VJ; Reid BJ; Odze RD
    Hum Pathol; 2006 Oct; 37(10):1304-15. PubMed ID: 16949933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
    Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M
    J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Her-2 in carcinomas of the esophagus.
    Schoppmann SF; Jesch B; Friedrich J; Wrba F; Schultheis A; Pluschnig U; Maresch J; Zacherl J; Hejna M; Birner P
    Am J Surg Pathol; 2010 Dec; 34(12):1868-73. PubMed ID: 21107094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics study of esophageal adenocarcinoma.
    Zhang J; Liu L; Wei S; Nagana Gowda GA; Hammoud Z; Kesler KA; Raftery D
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):469-75, 475.e1-4. PubMed ID: 20880550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of selected molecular markers in esophagus precancerous, adenocarcinoma and squamous cell carcinoma in Iranian subjects.
    Allameh A; Rasmi Y; Nasseri-Moghaddam S; Tavangar SM; Sharifi R; Sadreddini M
    Cancer Epidemiol; 2009 Jul; 33(1):79-84. PubMed ID: 19679052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinico-pathological study of the origin of adeno-carcinoma of the mid-thoracic oesophagus and results of surgical resection.
    Moghissi K; Papiri N
    Chirurgie; 1992; 118(5):298-303; discussion 304. PubMed ID: 1341284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
    Sano A; Kato H; Sakurai S; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Nakajima T; Kuwano H
    Ann Surg Oncol; 2009 Feb; 16(2):506-14. PubMed ID: 19050962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.
    Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS
    Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.